Compare PLX & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLX | FNWD |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.4M | 147.7M |
| IPO Year | 1996 | 1996 |
| Metric | PLX | FNWD |
|---|---|---|
| Price | $2.37 | $35.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 641.2K | 29.2K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.22 | ★ 0.52 |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $36.81 | $17.40 |
| Revenue Next Year | N/A | $5.44 |
| P/E Ratio | ★ $10.82 | $68.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.36 | $26.46 |
| 52 Week High | $3.19 | $39.99 |
| Indicator | PLX | FNWD |
|---|---|---|
| Relative Strength Index (RSI) | 64.79 | 54.67 |
| Support Level | $2.06 | $31.49 |
| Resistance Level | $2.42 | $35.27 |
| Average True Range (ATR) | 0.10 | 1.56 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 83.38 | 42.86 |
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.